CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
6291.4
1.38%
Market Trading Hours* (UTC) Opens on Thursday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 58.2
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011013 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011013%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011209 %
Charges from full value of position ($-2.13)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011209%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5%
Stock exchange Japan
Commission on trade 0%

*Information provided by Capital.com

Eisai Co Ltd ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 6205.7
Open* 6226.6
1-Year Change* -15.93%
Day's Range* 6226.6 - 6341.3
52 wk Range 6,863.00-11.25K
Average Volume (10 days) 1.55M
Average Volume (3 months) 24.65M
Market Cap 2,099.69B
P/E Ratio 42.22
Shares Outstanding 287.04M
Revenue 759.33B
EPS 167.70
Dividend (Yield %) 2.25989
Beta 0.64
Next Earnings Date Feb 6, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 28, 2024 6317.4 90.8 1.46% 6226.6 6323.3 6215.5
Feb 27, 2024 6205.7 -1.9 -0.03% 6207.6 6247.6 6150.8
Feb 26, 2024 6178.7 48.9 0.80% 6129.8 6264.5 6111.8
Feb 22, 2024 6145.8 25.9 0.42% 6119.9 6171.7 6105.9
Feb 21, 2024 6192.7 29.1 0.47% 6163.6 6243.6 6129.8
Feb 20, 2024 6268.5 29.9 0.48% 6238.6 6286.4 6163.6
Feb 19, 2024 6163.6 0.2 0.00% 6163.4 6396.1 6163.4
Feb 16, 2024 6163.5 -149.8 -2.37% 6313.3 6450.0 6163.4
Feb 15, 2024 6163.6 -297.3 -4.60% 6460.9 6482.9 6163.4
Feb 14, 2024 6518.8 -43.9 -0.67% 6562.7 6586.6 6454.0
Feb 13, 2024 6672.5 140.7 2.15% 6531.8 6674.4 6531.7
Feb 9, 2024 6554.7 70.8 1.09% 6483.9 6609.6 6462.0
Feb 8, 2024 6463.9 -27.0 -0.42% 6490.9 6508.9 6163.4
Feb 7, 2024 6512.9 349.4 5.67% 6163.5 6574.7 6163.4
Feb 6, 2024 6467.0 -300.1 -4.43% 6767.1 6810.1 6323.2
Feb 5, 2024 6783.1 20.9 0.31% 6762.2 6836.0 6712.3
Feb 2, 2024 6764.2 -115.7 -1.68% 6879.9 6895.9 6754.2
Feb 1, 2024 6901.8 -10.0 -0.14% 6911.8 6978.6 6876.9
Jan 31, 2024 6964.7 24.0 0.35% 6940.7 6989.6 6898.8
Jan 30, 2024 7001.6 -61.7 -0.87% 7063.3 7124.2 6986.6

Eisai Co., Ltd. Events

Time (UTC) Country Event
Thursday, March 28, 2024

Time (UTC)

12:00

Country

JP

Event

Eisai Co Ltd
Eisai Co Ltd

Forecast

-

Previous

-
Monday, May 13, 2024

Time (UTC)

03:30

Country

JP

Event

Full Year 2024 Eisai Co Ltd Earnings Release
Full Year 2024 Eisai Co Ltd Earnings Release

Forecast

-

Previous

-
Thursday, June 20, 2024

Time (UTC)

01:00

Country

JP

Event

Eisai Co Ltd Annual Shareholders Meeting
Eisai Co Ltd Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 744402 756226 645942 695621 642834
Revenue 744402 756226 645942 695621 642834
Cost of Revenue, Total 177776 165603 161257 167548 184245
Gross Profit 566626 590623 484685 528073 458589
Total Operating Expense 704362 702476 594431 570119 556680
Selling/General/Admin. Expenses, Total 348138 356672 273251 248554 223798
Research & Development 158058 158222 139431 125938 129411
Depreciation / Amortization 23151 21073 19267 18209 12762
Interest Expense (Income) - Net Operating 2199 2083 1453 -2279 622
Unusual Expense (Income) -1798 -1969 53 13007 6539
Other Operating Expenses, Total -3162 792 -281 -858 -697
Operating Income 40040 53750 51511 125502 86154
Interest Income (Expense), Net Non-Operating 3435 779 798 2889 3301
Net Income Before Taxes 45012 54458 52296 128063 89454
Net Income After Taxes 56836 45717 42306 122467 66483
Minority Interest -1404 2237 -364 -700 -3098
Net Income Before Extra. Items 55432 47954 41942 121767 63385
Net Income 55432 47954 41942 121767 63385
Total Adjustments to Net Income 1
Income Available to Common Excl. Extra. Items 55432 47954 41942 121767 63386
Income Available to Common Incl. Extra. Items 55432 47954 41942 121767 63386
Diluted Net Income 55432 47954 41942 121767 63386
Diluted Weighted Average Shares 286.761 286.729 286.713 286.648 286.664
Diluted EPS Excluding Extraordinary Items 193.304 167.245 146.286 424.796 221.116
Dividends per Share - Common Stock Primary Issue 160 160 160 160 150
Diluted Normalized EPS 185.606 161.509 146.269 469.08 238.069
Other, Net -61 -61 -72 -61 -1
Gain (Loss) on Sale of Assets 1598 -10 59 -267
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 198205 187572 174364 184262 190901
Revenue 198205 187572 174364 184262 190901
Cost of Revenue, Total 38565 46735 45132 47404 50738
Gross Profit 159640 140837 129232 136858 140163
Total Operating Expense 171988 179002 176545 176828 211500
Selling/General/Admin. Expenses, Total 85322 92581 88083 92306 110268
Research & Development 51596 39886 43018 38499 48349
Other Operating Expenses, Total -3495 -200 312 -1381 2139
Operating Income 26217 8570 -2181 7434 -20599
Interest Income (Expense), Net Non-Operating 1206 886 594 2287 25
Other, Net -1 1 -1
Net Income Before Taxes 27422 9456 -1587 9722 -20575
Net Income After Taxes 15912 9123 3833 27970 -13717
Minority Interest 412 -479 -264 -1072 1468
Net Income Before Extra. Items 16324 8644 3569 26898 -12249
Net Income 16324 8644 3569 26898 -12249
Income Available to Common Excl. Extra. Items 16323 8644 3568 26897 -12249
Income Available to Common Incl. Extra. Items 16323 8644 3568 26897 -12249
Diluted Net Income 16323 8644 3568 26897 -12249
Diluted Weighted Average Shares 286.806 286.795 286.74 286.722 286.694
Diluted EPS Excluding Extraordinary Items 56.913 30.14 12.4433 93.8086 -42.725
Dividends per Share - Common Stock Primary Issue 80 0 80 0 80
Diluted Normalized EPS 56.913 30.14 12.4433 93.8086 -42.7114
Unusual Expense (Income) 6
Total Adjustments to Net Income -1 -1 -1
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 622202 640606 518344 521405 561677
Cash and Short Term Investments 267890 310065 249007 255799 293977
Cash & Equivalents 225710 264389 206985 254244 286434
Short Term Investments 42180 45676 42022 1555 7543
Total Receivables, Net 187256 207950 160310 180022 156641
Accounts Receivable - Trade, Net 161162 194046 147387 170063 137336
Total Inventory 140417 99008 85118 65735 67890
Other Current Assets, Total 26639 23583 23909 19849 43169
Total Assets 1263350 1239320 1088430 1062140 1071520
Property/Plant/Equipment, Total - Net 166633 169926 160933 144638 105172
Property/Plant/Equipment, Total - Gross 400049 399080 375531 345032 298597
Accumulated Depreciation, Total -233417 -229155 -214598 -200393 -193424
Goodwill, Net 208817 191758 171783 168682 172157
Intangibles, Net 89230 95451 106419 106094 98144
Long Term Investments 52463 44033 43817 39779 53005
Other Long Term Assets, Total 124005 97541 87131 81542 81365
Total Current Liabilities 298945 313333 256017 251965 295735
Accounts Payable 33954 29631 28300 31007 31253
Notes Payable/Short Term Debt 31201 0 0 0 9000
Current Port. of LT Debt/Capital Leases 10000 0 39985 34994 39993
Other Current Liabilities, Total 223790 283702 187732 185964 215489
Total Liabilities 463391 490493 386826 384013 443401
Total Long Term Debt 84904 94893 49908 54945 89905
Long Term Debt 84904 94893 49908 54945 89905
Deferred Income Tax 664 483 511 569 282
Minority Interest 22612 22712 24759 24503 23862
Other Liabilities, Total 56266 59072 55631 52031 33617
Total Equity 799959 748822 701601 678127 628119
Common Stock 44986 44986 44986 44986 44986
Additional Paid-In Capital 78813 77605 77628 77609 77590
Retained Earnings (Accumulated Deficit) 522774 506583 506403 505359 438489
Treasury Stock - Common -33638 -33936 -34049 -34338 -34671
Other Equity, Total 187024 153584 106633 84511 101725
Total Liabilities & Shareholders’ Equity 1263350 1239320 1088430 1062140 1071520
Total Common Shares Outstanding 286.899 286.766 286.666 286.664 286.521
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 659269 640074 622202 610118 585379
Cash and Short Term Investments 281953 271118 267890 268985 265527
Cash & Equivalents 281452 269305 225710 268002 264527
Short Term Investments 501 1813 42180 983 1000
Total Receivables, Net 191910 189206 187256 188996 178091
Accounts Receivable - Trade, Net 191910 189206 161162 188996 178091
Total Inventory 159973 149935 140417 120863 114410
Other Current Assets, Total 25433 29815 26639 31274 27351
Total Assets 1333990 1305090 1263350 1251070 1261280
Property/Plant/Equipment, Total - Net 165291 166000 166633 165160 175688
Property/Plant/Equipment, Total - Gross 400049
Accumulated Depreciation, Total -233417
Goodwill, Net 233513 226417 208817 207487 226206
Intangibles, Net 86033 87555 89230 89111 93772
Long Term Investments 63090 61560 52463 45868 48199
Other Long Term Assets, Total 126797 123487 124005 133325 132034
Total Current Liabilities 307306 295869 298945 313676 266536
Accounts Payable 61089 61434 33954 68871 76827
Notes Payable/Short Term Debt 0 0 31201 0 0
Current Port. of LT Debt/Capital Leases 48305 51302 10000 65200 9998
Other Current Liabilities, Total 197912 183133 223790 179605 179711
Total Liabilities 472324 460224 463391 477035 433151
Total Long Term Debt 84922 84913 84904 84920 84912
Long Term Debt 84922 84913 84904 84920 84912
Deferred Income Tax 480 768 664 1221 1005
Minority Interest 23176 22793 22612 23038 22576
Other Liabilities, Total 56440 55881 56266 54180 58122
Total Equity 861669 844869 799959 774034 828127
Common Stock 44986 44986 44986 44986 44986
Additional Paid-In Capital 78863 78838 78813 78813 78813
Retained Earnings (Accumulated Deficit) 526663 523632 522774 504946 518186
Treasury Stock - Common -33603 -33622 -33638 -33634 -33623
Other Equity, Total 244760 231035 187024 178923 219765
Total Liabilities & Shareholders’ Equity 1333990 1305090 1263350 1251070 1261280
Total Common Shares Outstanding 287.037 287.037 286.899 286.9 286.901
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 45012 54458 52296 128063 89454
Cash From Operating Activities -1772 117589 73067 102782 103714
Cash From Operating Activities 39981 38398 35767 33700 26841
Non-Cash Items 2019 11429 213 12296 7330
Cash Taxes Paid 22612 7109 16822 19331 16568
Cash Interest Paid 1484 1286 1026 1079 1419
Changes in Working Capital -88784 13304 -15209 -71277 -19911
Cash From Investing Activities -22723 -28848 -36086 -27625 -7918
Capital Expenditures -34559 -40467 -37358 -50226 -27622
Other Investing Cash Flow Items, Total 11836 11619 1272 22601 19704
Cash From Financing Activities -24522 -48967 -55908 -103528 -79180
Financing Cash Flow Items 83 2317 2 252 -552
Total Cash Dividends Paid -45893 -45878 -45868 -45849 -42957
Issuance (Retirement) of Debt, Net 21288 -5406 -10042 -57931 -35671
Foreign Exchange Effects 6735 21118 13424 -9309 4783
Net Change in Cash -42282 60892 -5503 -37680 21399
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 45012 17590 8134 9722 54458
Cash From Operating Activities -1772 -25763 -18846 3945 117589
Cash From Operating Activities 39981 29847 19693 9803 38398
Non-Cash Items 2019 272 272 11429
Cash Taxes Paid 22612 18089 12962 4542 7109
Cash Interest Paid 1484 993 710 296 1286
Changes in Working Capital -88784 -73472 -46945 -15580 13304
Cash From Investing Activities -22723 -20183 -16408 -16832 -28848
Capital Expenditures -34559 -27862 -20720 -15889 -40467
Other Investing Cash Flow Items, Total 11836 7679 4312 -943 11619
Cash From Financing Activities -24522 1918 -27800 -25240 -48967
Financing Cash Flow Items 83 -9 25 74 2317
Total Cash Dividends Paid -45893 -45893 -22941 -22941 -45878
Issuance (Retirement) of Debt, Net 21288 47820 -4884 -2373 -5406
Foreign Exchange Effects 6735 2398 17948 16309 21118
Net Change in Cash -42282 -41630 -45106 -21818 60892
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Wellington Management Company, LLP Investment Advisor/Hedge Fund 6.9977 20752870 -3008210 2022-08-31 LOW
Nomura Asset Management Co., Ltd. Investment Advisor 5.7332 17002671 -147600 2023-09-30 LOW
Nippon Life Insurance Company Insurance Company 2.8988 8597000 -2943045 2023-03-31 LOW
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 2.8433 8432400 251666 2023-09-29 LOW
Mitsubishi UFJ Trust and Banking Corporation Bank and Trust 2.7863 8263246 8263246 2022-10-31 LOW
Daiwa Asset Management Co., Ltd. Investment Advisor 2.7331 8105473 89057 2023-09-30 LOW
Sumitomo Mitsui Trust Asset Management Co., Ltd. Investment Advisor 2.6708 7920600 7837126 2023-09-29 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.5025 7421599 18900 2023-09-30 LOW
Capital Research Global Investors Investment Advisor 2.2204 6584900 -51000 2023-09-30 LOW
Saitama Resona Bank, Ltd. Bank and Trust 1.7871 5300000 -500000 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.6362 4852521 -61900 2023-09-30 LOW
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. Investment Advisor 1.6255 4820600 1065402 2022-10-31 LOW
Naito Foundation Corporation 1.4203 4212000 0 2023-03-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.338 3968000 3968000 2023-03-31 MED
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.2774 3788404 359404 2022-12-31 LOW
BlackRock Japan Co., Ltd. Investment Advisor 0.6352 1883700 -24500 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5604 1661909 400 2023-09-30 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5304 1572952 18200 2023-09-30 LOW
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 0.4461 1323000 23000 2023-06-30 LOW
Asset Management One Co., Ltd. Investment Advisor/Hedge Fund 0.4097 1215129 -6200 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eisai Co., Ltd. Company profile

About Eisai Co., Ltd

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Eisai Co., Ltd revenues increased 13% to Y565.33B. Net income applicable to common stockholders increased 34% to Y60.36B. Revenues reflect Other Business segment increase from Y43.85B to Y92.54B, Pharmaceutical Business segment increase of 3% to Y449.48B, China segment increase of 25% to Y83.14B, America segment increase of 13% to Y125.19B, Asia/Latin America segment increase of 10% to Y38.04B.

Equity composition

FY'99-02 WAS & FY'04 DWAS were estimated. FY'03 DWAS was adjusted to reflect reported DEPS. FY'04-06 1Q&3Q WAS & O/S were estimated. 12/05 DPS estimated. FY'08 Q1&Q3 DWAS were estimated. FY'08 Q1&Q3 WAS = O/S. FY'11 Q3 DWAS estimated.

Industry: Pharmaceuticals (NEC)

エーザイ本館
小石川4-6-10
BUNKYO-KU
TOKYO-TO 112-8088
JP

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,876.40 Price
-0.510% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

61,252.20 Price
+7.760% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.57 Price
-3.030% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,031.48 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading